About: Effects of a fructose-rich diet and the aldose reductase inhibitor, ONO-2235, on the development of diabetic neuropathy in streptozotocin-treated rats

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Effects of a fructose-rich diet and the aldose reductase inhibitor, ONO-2235, on the development of diabetic neuropathy in streptozotocin-treated rats Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 March 1985

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в березні 1985 (uk) im März 1985 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en marzu de 1985 (ast) scientific article published on 01 March 1985 (en)
publication date	wds:Q69946134-4C4AA6D1-3BF4-4812-A644-21AF5121BABE
publication date	1985-03-01 00:00:00Z (xsd:dateTime)
exact match	wds:Q69946134-BC0743D3-5DE0-4885-9F67-F3E2C6EFB998
exact match	https://scigraph.springernature.com/pub.10.1007/bf00273868
cites work	wds:Q69946134-00E0971C-27F9-48C7-9BFE-6418B2203A76 wds:Q69946134-1573B7DB-1362-4E06-A5F6-E1583EDD876F wds:Q69946134-2B3AC449-9319-487F-9D31-466A70362226 wds:Q69946134-34122920-6A87-41E1-BC0B-7C00EF879D69 wds:Q69946134-4051B639-2491-44BA-A99A-52FE399740AE wds:Q69946134-423E9698-E59B-4A67-A2DF-27DAA70B3AE6 wds:Q69946134-5A1E36E0-803C-4F20-9535-A15ABE5C47BA wds:Q69946134-5D030C48-1F13-49A6-AC0D-B324623F11FF wds:Q69946134-687C213D-8EAD-4C66-AC2B-414ED923541C wds:Q69946134-69777C57-72F4-4E67-8968-49B3F73D23F0 wds:Q69946134-697C5B0C-B9C6-4323-AB62-CA5B5A108B65 wds:Q69946134-6A7B1032-B002-424E-8EEE-B5C36252E3E1 wds:Q69946134-82B4B0A1-FF08-45C8-ABAA-861859B346BB wds:Q69946134-BEC706AA-E4A0-47E3-820A-7346990E52C2 wds:Q69946134-CABB0830-BC81-4516-B20E-82E33F62F3DB wds:Q69946134-D1695E91-F227-4788-B796-B0734E542BEA wds:Q69946134-D89E3CAE-DEC1-4C18-B9F7-4E989A7BC4B8 wds:Q69946134-E290CC65-968E-469B-B138-5545DD794B8C wds:Q69946134-E4FA195A-A61B-45E5-9B5F-6880360EE8A7 wds:Q69946134-E7D16318-ACD4-4AF6-9029-13ED205DA19C
cites work	Serial in vivo determinations of nerve conduction velocity in rat tails. Physiological and pathological changes. The sorbitol pathway and the complications of diabetes Reversal, by treatment with an aldose reductase inhibitor, of impaired axonal transport and motor nerve conduction velocity in experimental diabetes mellitus Aldose reductase inhibition improves nerve conduction velocity in diabetic patients Clinical trial of an aldose reductase inhibitor in diabetic neuropathy Red cell sorbitol: an indicator of diabetic control Peripheral nerves in early experimental diabetes: expansion of the endoneurial space as a cause of increased water content Diabetes induced by a high fructose diet Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats CP-45,634: A novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic rats Hyperglycemia, Polyol Metabolism, and Complications of Diabetes Mellitus Polyol accumulation in galactosemic and diabetic rats: control by an aldose reductase inhibitor Diabetic Neuropathy—New Concepts of Its Etiology Treatment of severely painful diabetic neuropathy with an aldose reductase inhibitor: relief of pain and improved somatic and autonomic nerve function Metabolic abnormalities in diabetic peripheral nerve: Relation to impaired function Effect of a new aldose reductase inhibitor, (E)-3-carboxymethyl-5-[(2E)-methyl-3-phenylpropenylidene]rhodanine (ONO-2235) on peripheral nerve disorders in streptozotocin-diabetic rats Glucose utilization by the polyol pathway in human erythrocytes Effects of aldose reductase inhibitor treatment in diabetic polyneuropathy - a clinical and neurophysiological study. Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic rats
author name string	wds:Q69946134-2C3F20C7-B271-48CB-BA1D-76B3DC7D93D5 wds:Q69946134-5725B1F5-7B5A-49E1-B563-31EC214E0E79 wds:Q69946134-7A909457-D856-4580-B7A1-073BCC10CEEC wds:Q69946134-83D7D02A-48C7-4073-B477-6B3610DAA17D wds:Q69946134-8F602D38-DE21-4B01-B909-8E5366702DDE wds:Q69946134-96DFE988-A6C0-4A12-9A86-DADBFBC2045C wds:Q69946134-A630F25F-F542-46E6-A6CF-38C799FF68DC wds:Q69946134-D72D5DF7-602A-4836-94BE-E23D0F0B6BFF wds:Q69946134-EA98F9BD-76B9-4B33-92EF-51694E9F4FCA
author name string	M Kimura H Fukasawa N Sakamoto T Morimura H Kakuta M Iida N Hotta H Terashima N Koh
rdfs:label	Effects of a fructose-rich diet and the aldose reductase inhibitor, ONO-2235, on the development of diabetic neuropathy in streptozotocin-treated rats (en) Effects of a fructose-rich diet and the aldose reductase inhibitor, ONO-2235, on the development of diabetic neuropathy in streptozotocin-treated rats (nl)
skos:prefLabel	Effects of a fructose-rich diet and the aldose reductase inhibitor, ONO-2235, on the development of diabetic neuropathy in streptozotocin-treated rats (en) Effects of a fructose-rich diet and the aldose reductase inhibitor, ONO-2235, on the development of diabetic neuropathy in streptozotocin-treated rats (nl)
name	Effects of a fructose-rich diet and the aldose reductase inhibitor, ONO-2235, on the development of diabetic neuropathy in streptozotocin-treated rats (en) Effects of a fructose-rich diet and the aldose reductase inhibitor, ONO-2235, on the development of diabetic neuropathy in streptozotocin-treated rats (nl)
title	wds:Q69946134-3166526F-AB48-4384-B7A8-19620FC22173
title	Effects of a fructose-rich diet and the aldose reductase inhibitor, ONO-2235, on the development of diabetic neuropathy in streptozotocin-treated rats (en)
page(s)	wds:Q69946134-948CDE9D-613D-409C-9A7A-E9225E7A5A92
page(s)	176-180
instance of	wds:Q69946134-A8EA506F-A251-4C00-A5BE-252EAB2630B6
instance of	scholarly article
main subject	wds:Q69946134-CEC28E6D-06CA-4F9C-AEC3-2664EBB7574B
main subject	diabetic neuropathy
PubMed ID	wds:Q69946134-E5454B4D-2FEF-4506-8705-A627F7F87A57
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3922829
PubMed ID	3922829
published in	wds:Q69946134-1CB916B4-3B61-44DE-A551-86EAC0EB623C
published in	Diabetologia
issue	wds:Q69946134-9B9A17FE-B65C-43CD-80EA-9B601779BAFA
volume	wds:Q69946134-F6B9C63D-8A3D-41B6-921E-D872D1EB8164
issue	3
volume	28
Dimensions Publication ID	wds:Q69946134-530041F9-6EE5-4E35-96BA-756B59438AEE
Dimensions Publication ID	1080036219
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q69946134
is cites work of	Improvement of corneal fluorescein staining in post cataract surgery of diabetic patients by an oral aldose reductase inhibitor, ONO-2235. Epalrestat. A review of its pharmacology, and therapeutic potential in late-onset complications of diabetes mellitus Epalrestat, an aldose reductase inhibitor, in diabetic neuropathy: an Indian perspective Human erythrocyte sorbitol metabolism and the role of sorbitol dehydrogenase In vitro retinal and erythrocyte polyol pathway regulation by hormones and an aldose reductase inhibitor Effects of propionyl-L-carnitine and insulin on the electroretinogram, nerve conduction and nerve blood flow in rats with streptozotocin-induced diabetes

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software